Davenport & Co’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Sell |
12,100
-9,600
| -44% | -$108K | ﹤0.01% | 1161 |
|
|
2025
Q1 | $219K | Sell |
21,700
-138,440
| -86% | -$1.4M | ﹤0.01% | 1080 |
|
|
2024
Q4 | $1.89M | Sell |
160,140
-101,300
| -39% | -$1.2M | 0.01% | 478 |
|
|
2024
Q3 | $3.02M | Sell |
261,440
-30,860
| -11% | -$356K | 0.02% | 379 |
|
|
2024
Q2 | $3.09M | Sell |
292,300
-14,400
| -5% | -$152K | 0.02% | 362 |
|
|
2024
Q1 | $3.23M | Buy |
306,700
+23,620
| +8% | +$249K | 0.02% | 357 |
|
|
2023
Q4 | $3.18M | Buy |
283,080
+5,100
| +2% | +$57.3K | 0.02% | 331 |
|
|
2023
Q3 | $3.25M | Buy |
277,980
+23,400
| +9% | +$273K | 0.02% | 301 |
|
|
2023
Q2 | $2.57M | Buy |
254,580
+47,480
| +23% | +$479K | 0.02% | 349 |
|
|
2023
Q1 | $1.53M | Buy |
+207,100
| New | +$1.53M | 0.01% | 416 |
|